unisolve
intervet ireland limited - solvent for parenteral use - immunological - diluent - avian bovine ovine
unisol 100 mg/ml solution for injection for cattle and pigs
vetpharma animal health, s.l - enrofloxacin - solution for injection - antimicrobial - cattle, pigs
unisolve
intervet uk ltd - see spc -
unisol 0.5% w/v oral solution for piglets
universal farma, s.l - enrofloxacin -
uni-sol- sodium salicylate solution
animal science products inc - sodium salicylate (unii: wiq1h85syp) (salicylic acid - unii:o414pz4lpz) - for use in the drinking water of poultry and swine as an aid in reducing pain, fever and inflammation
algex nasal mist
douglas pharmaceuticals limited - flunisolide 25ug - nasal spray solution - 25 mcg/dose - active: flunisolide 25ug
rhinalar nasal mist
roche products (nz) ltd - flunisolide 0.025% - nasal spray solution - 0.02 % - active: flunisolide 0.025%
singulair- montelukast sodium tablet, chewable singulair- montelukast sodium tablet, film coated
dispensing solutions inc. - montelukast sodium (unii: u1o3j18sfl) (montelukast - unii:mhm278sd3e) - montelukast 5 mg - singulair is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older. singulair is indicated for prevention of exercise-induced bronchoconstriction in patients 15 years of age and older. singulair is indicated for the relief of symptoms of allergic rhinitis (seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older, and perennial allergic rhinitis in adults and pediatric patients 6 months of age and older). hypersensitivity to any component of this product.
montelukast sodium - montelukast sodium tablet, chewable
a-s medication solutions - montelukast sodium (unii: u1o3j18sfl) (montelukast - unii:mhm278sd3e) - montelukast 5 mg - montelukast sodium is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 2 years of age and older. montelukast sodium is indicated for prevention of exercise-induced bronchoconstriction (eib) in patients 6 years of age and older. montelukast sodium is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 2 years of age and older. - hypersensitivity to any component of this product. pregnancy category b: there are no adequate and well-controlled studies in pregnant women. because animal reproduction studies are not always predictive of human response, montelukast sodium should be used during pregnancy only if clearly needed. teratogenic effect: no teratogenicity was observed in rats and rabbits at doses approximately 100 and 110 times, respectively, the maximum recommended daily oral dose in adults based on aucs [see nonclinical toxicology (13.2)] . during worl